Home Privacy Archive Realtime Report

Stock Trading History of Tansey Michael James Byron

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tansey Michael James Byron since year 2005. The trader's CIK number is 1369013. At the time of this reporting, Tansey Michael James Byron is the Executive VP & CMO of La Jolla Pharmaceutical Co (stock ticker symbol LJPC).

Stock purchases, sales, and option exercises reported by *Tansey Michael James Byron* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-02-05	LJPC	La Jolla Pharmaceutical Co	Purchase	1,900	3.10	5,899

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tansey Michael James Byron (Executive VP & CMO of La Jolla Pharmaceutical Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.